세계의 바이러스성 간염 및 레트로바이러스 진단 검사 시장

Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $7.7 Billion by 2030

The global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$4.4 Billion in the year 2023, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the period 2023-2030.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 11.3% CAGR

The Viral Hepatitis and Retrovirus Diagnostic Tests market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 11.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 6.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 31 Featured) -

• Abbott Diagnostics
• Amkay Products
• AOV International
• Apothecaries Sundries Manufacturing
• BD
• Beckman Coulter
• Bhat Bio-tech
• BioMerieux
• Bioneovan
• Bio-Rad
• Cepheid
• Chembio
• DiaSorin
• Enzo Biochem
• Fujirebio
• Gemc Technology
• Grifols
• Hangzhou Deangel Biological Engineering
• Hangzhou Heo Bio-Tech
• Hologic
• Horiba
• Innovation Biotech
• Jaksh Enterprises
• Krishco Medical Products
• Roche Diagnostics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Viral Hepatitis and Retrovirus Diagnostic Tests - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Viral Hepatitis and Retrovirus Diagnostic Tests Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 5: USA Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 6: USA Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• CANADA
  • TABLE 7: Canada Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 8: Canada Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• JAPAN
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 9: Japan Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 10: Japan Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• CHINA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 11: China Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 12: China Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• EUROPE
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 13: Europe Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 14: Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 15: Europe 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
• FRANCE
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 16: France Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 17: France Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• GERMANY
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 18: Germany Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 19: Germany Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• ITALY
  • TABLE 20: Italy Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Italy Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• UNITED KINGDOM
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 22: UK Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 23: UK Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• SPAIN
  • TABLE 24: Spain Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Spain Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• RUSSIA
  • TABLE 26: Russia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Russia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• REST OF EUROPE
  • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Rest of Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• ASIA-PACIFIC
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 31: Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 32: Asia-Pacific 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
• AUSTRALIA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 33: Australia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 34: Australia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• INDIA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 35: India Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: India Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• SOUTH KOREA
  • TABLE 37: South Korea Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 38: South Korea Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• REST OF ASIA-PACIFIC
  • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 40: Rest of Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• LATIN AMERICA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 41: Latin America Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 42: Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Latin America 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 44: Argentina Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Argentina Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• BRAZIL
  • TABLE 46: Brazil Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 47: Brazil Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• MEXICO
  • TABLE 48: Mexico Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 49: Mexico Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• REST OF LATIN AMERICA
  • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• MIDDLE EAST
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 52: Middle East Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 53: Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 54: Middle East 16-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
• IRAN
  • TABLE 55: Iran Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 56: Iran Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• ISRAEL
  • TABLE 57: Israel Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 58: Israel Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• SAUDI ARABIA
  • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Saudi Arabia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• UNITED ARAB EMIRATES
  • TABLE 61: UAE Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 62: UAE Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• REST OF MIDDLE EAST
  • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 64: Rest of Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
• AFRICA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 65: Africa Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Africa Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR

IV. COMPETITION